PL372071A1 - Stabilizowane kompozycje farmaceutyczne oparte napolioksyetylenowanym oleju rycynowym oraz sposób ich wytwarzania - Google Patents

Stabilizowane kompozycje farmaceutyczne oparte napolioksyetylenowanym oleju rycynowym oraz sposób ich wytwarzania

Info

Publication number
PL372071A1
PL372071A1 PL03372071A PL37207103A PL372071A1 PL 372071 A1 PL372071 A1 PL 372071A1 PL 03372071 A PL03372071 A PL 03372071A PL 37207103 A PL37207103 A PL 37207103A PL 372071 A1 PL372071 A1 PL 372071A1
Authority
PL
Poland
Prior art keywords
basis
manufacturing
pharmaceutical compositions
same
castor oil
Prior art date
Application number
PL03372071A
Other languages
English (en)
Inventor
Vladimir Kysilka
Libuse Zatloukalova
Borek Zaludek
Karel Pospisilik
Marie Cigankova
Martin Kubat
Ales Cirkva
Original Assignee
Pliva-Lachema A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva-Lachema A.S. filed Critical Pliva-Lachema A.S.
Publication of PL372071A1 publication Critical patent/PL372071A1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL03372071A 2002-06-10 2003-05-16 Stabilizowane kompozycje farmaceutyczne oparte napolioksyetylenowanym oleju rycynowym oraz sposób ich wytwarzania PL372071A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ20022027A CZ294371B6 (cs) 2002-06-10 2002-06-10 Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy

Publications (1)

Publication Number Publication Date
PL372071A1 true PL372071A1 (pl) 2005-07-11

Family

ID=29721409

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03372071A PL372071A1 (pl) 2002-06-10 2003-05-16 Stabilizowane kompozycje farmaceutyczne oparte napolioksyetylenowanym oleju rycynowym oraz sposób ich wytwarzania

Country Status (19)

Country Link
US (1) US20050142225A1 (pl)
EP (1) EP1515751A1 (pl)
JP (1) JP2005534656A (pl)
KR (1) KR20050010030A (pl)
CN (1) CN1655824A (pl)
AU (1) AU2003240661A1 (pl)
BR (1) BR0311687A (pl)
CA (1) CA2487889A1 (pl)
CZ (1) CZ294371B6 (pl)
EA (1) EA007223B1 (pl)
HR (1) HRP20041107A2 (pl)
IL (2) IL165027A0 (pl)
IS (1) IS7551A (pl)
MX (1) MXPA04011990A (pl)
NZ (1) NZ537150A (pl)
PL (1) PL372071A1 (pl)
RS (1) RS106704A (pl)
WO (1) WO2003103714A1 (pl)
ZA (1) ZA200408892B (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2563533C (en) 2004-04-15 2013-10-01 Shmuel A. Ben-Sasson Compositions capable of facilitating penetration across a biological barrier
GT200500310A (es) 2004-11-19 2006-06-19 Compuestos organicos
AU2006212177A1 (en) * 2005-02-10 2006-08-17 Sindan Pharma Srl Method of purifying a surfactant by ultrafiltration
EP1690551A3 (en) 2005-02-10 2006-10-18 Sindan Pharma Srl Method of purifying a surfactant by ultrafiltration
SA06270147B1 (ar) 2005-06-09 2009-12-22 نوفارتيس ايه جي عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
DE102008011691A1 (de) * 2008-02-28 2009-09-10 Schülke & Mayr GmbH Stabilisierte, antimikrobiell wirksame Zusammensetzung mit einem Gehalt an Bispyridiniumalkan
CN101596159B (zh) * 2008-06-03 2012-12-19 哈药集团生物工程有限公司 一种紫杉醇注射液及其制备方法
KR101814186B1 (ko) 2008-09-17 2018-03-14 키아스마 인코포레이티드 약제학적 조성물 및 연관된 투여방법
KR20110087297A (ko) * 2008-11-21 2011-08-02 베링거 인겔하임 인터내셔날 게엠베하 경구 투여용의 강력한 hcv 억제제의 약제학적 조성물
MY154683A (en) 2009-07-07 2015-07-15 Boehringer Ingelheim Int Pharmaceutical composition for a hepatitis c viral protease inhibitor
CN101829051B (zh) * 2010-05-31 2012-09-12 南昌弘益科技有限公司 1’-乙酰氧基胡椒酚乙酸酯注射液
WO2016126830A1 (en) 2015-02-03 2016-08-11 Chiasma Inc. Method of treating diseases
CN105497905A (zh) * 2015-12-30 2016-04-20 钟术光 一种供注射或口服用的辅料
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods
CN112778513A (zh) * 2020-12-30 2021-05-11 江苏优仿医药科技有限公司 一种聚氧乙烯蓖麻油的精制方法及其应用
CN113281425B (zh) * 2021-04-15 2023-06-06 四川汇宇制药股份有限公司 一种聚氧乙烯(35)蓖麻油中游离脂肪酸的检测方法
CN116328361A (zh) * 2023-03-23 2023-06-27 四川汇宇制药股份有限公司 稳定的紫杉醇溶液及其制备方法和用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55108823A (en) * 1979-02-13 1980-08-21 Takemoto Oil & Fat Co Ltd Purification of alkylene oxide addition compound
US5112750A (en) * 1985-06-25 1992-05-12 Asama Chemical Co., Ltd. Immobilized cells and culture method utilizing the same
JPH02157274A (ja) * 1988-12-07 1990-06-18 Sumitomo Heavy Ind Ltd 植物油からビタミンeを分離濃縮する方法
US6150398A (en) * 1991-05-08 2000-11-21 The United States Of America As Represented By The Department Of Health And Human Services Methods for the treatment of cancer
CA2086874E (en) * 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
CA2145190A1 (en) * 1992-09-22 1994-03-31 The Government Of The United States Of America As Represented By The Sec Retary, Department Of Health And Human Services Use of taxol for treating lymphomas and breast cancer
WO1994012198A1 (en) * 1992-11-27 1994-06-09 F.H. Faulding & Co. Limited Injectable taxol composition
AU5612694A (en) * 1992-11-27 1994-06-22 Napro Biotherapeutics, Inc. Injectable composition
CA2092271C (en) * 1993-03-09 2009-10-13 Eddie Reed Use of g-csf for treating taxol side-effects
CA2472404A1 (en) * 1993-07-19 1995-02-02 Angiotech Pharmaceuticals, Inc. Combination of stent and anti-angiogenic factor
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
ATE201962T1 (de) * 1995-04-28 2001-06-15 Loders Croklaan Bv An polyungesättigten fettsäuren reiche triglyceride
DE19536165A1 (de) * 1995-09-28 1997-04-03 Basf Ag Verfahren zur Reinigung von alkoxylierten Fetten
US5925776A (en) * 1997-12-24 1999-07-20 Schein Pharmacetical, Inc. Polyethoxylated castor oil, process of making the same and formulations thereof
JP2000044840A (ja) * 1998-07-28 2000-02-15 Mitsubishi Heavy Ind Ltd 燃料ガス漏洩検知塗膜
AU1214400A (en) * 1998-10-20 2000-05-08 Ben Venue Laboratories, Inc. Process for purification of solvents useful in the preparation of pharmaceuticalcompositions
JP4697569B2 (ja) * 1999-09-22 2011-06-08 日本アエロジル株式会社 表面改質シリカ微粉末とその用途
JP2001247847A (ja) * 2000-03-03 2001-09-14 Nisshin Oil Mills Ltd:The 水性ゲル化剤
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability

Also Published As

Publication number Publication date
EA200401625A1 (ru) 2005-06-30
KR20050010030A (ko) 2005-01-26
IL165027A0 (en) 2005-12-18
AU2003240661A1 (en) 2003-12-22
EP1515751A1 (en) 2005-03-23
IL165027A (en) 2009-12-24
ZA200408892B (en) 2006-01-25
CA2487889A1 (en) 2003-12-18
CN1655824A (zh) 2005-08-17
CZ294371B6 (cs) 2004-12-15
US20050142225A1 (en) 2005-06-30
BR0311687A (pt) 2008-01-15
CZ20022027A3 (cs) 2004-01-14
JP2005534656A (ja) 2005-11-17
NZ537150A (en) 2006-09-29
IS7551A (is) 2004-11-25
HRP20041107A2 (en) 2005-02-28
EA007223B1 (ru) 2006-08-25
RS106704A (sr) 2006-12-15
WO2003103714A1 (en) 2003-12-18
MXPA04011990A (es) 2005-08-16

Similar Documents

Publication Publication Date Title
PL372071A1 (pl) Stabilizowane kompozycje farmaceutyczne oparte napolioksyetylenowanym oleju rycynowym oraz sposób ich wytwarzania
AU2002358270A1 (en) Zero-order sustained released dosage forms and method of making the same
GB2402063B (en) Pharmaceutical composition for controlled release of active substances and the manufacturing method thereof
IL158523A0 (en) Epothilone derivatives and pharmaceutical compositions containing the same
GB2374640B (en) Sliding bearing and method of manufacturing the same
ZA200502495B (en) Ester compound and medicinal use thereof.
IL166232A0 (en) Azaindole derivatives and pharmaceutical compositions containing the same
IL169112A (en) Phosphonooxy quinazoline derivatives and their pharmaceutical use
IL158041A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
EP1666178A4 (en) COMPOSITE EXTENSIBLE ELEMENT AND METHOD FOR MANUFACTURING THE SAME
IL162548A0 (en) 4-Oxoquinoline derivatives and pharmaceutical compositions containing the same
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
PL372084A1 (pl) Związek pochodnej 8-azaprostaglandyny i środek zawierający ten związek jako składnik aktywny
PL377854A1 (pl) Farmaceutyczne preparaty donosowe oraz sposoby ich stosowania
IL166482A0 (en) Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same
IL164699A0 (en) Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
IL164022A0 (en) Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same
EP1557415A4 (en) Heterocyclic compounds and antitumor agents containing them as an active ingredient
TWI366202B (en) Multilayer chip varistor and method of manufacturing the same
SG116507A1 (en) Pharmaceutical dosage form and method of making.
HUP0303948A2 (hu) Szájban diszpergálódó szilárd gyógyszerforma
AU2003254803A1 (en) Sliding part and method of manufacturing the sliding part
HRP20031067A2 (en) Pharmaceutical formulation having masked taste and method for the production thereof
EP1603800A4 (en) MULTILAYER STRUCTURES, PACKAGING AND METHODS OF MANUFACTURING MULTILAYER STRUCTURES
IL159006A0 (en) Phenoxy-phenyl derivatives and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)